These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33991113)

  • 1. Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo.
    Vecchio LM; Sullivan P; Dunn AR; Bermejo MK; Fu R; Masoud ST; Gregersen E; Urs NM; Nazari R; Jensen PH; Ramsey A; Goldstein DS; Miller GW; Salahpour A
    J Neurochem; 2021 Aug; 158(4):960-979. PubMed ID: 33991113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for "Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo".
    Masato A; Bubacco L; Greggio E
    J Neurochem; 2021 Aug; 158(4):833-836. PubMed ID: 34184261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease.
    Morrow BA; Roth RH; Redmond DE; Elsworth JD
    Neuroscience; 2011 Aug; 189():277-85. PubMed ID: 21640165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semichronic inhibition of glutathione reductase promotes oxidative damage to proteins and induces both transcription and translation of tyrosine hydroxylase in the nigrostriatal system.
    Romero-Ramos M; Venero JL; Garcia-Rodriguez S; Ayala A; Machado A; Cano J
    Free Radic Res; 2003 Sep; 37(9):1003-12. PubMed ID: 14670008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.
    Mexas LM; Florang VR; Doorn JA
    Neurotoxicology; 2011 Aug; 32(4):471-7. PubMed ID: 21514317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
    Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine.
    Rabinovic AD; Lewis DA; Hastings TG
    Neuroscience; 2000; 101(1):67-76. PubMed ID: 11068137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a binge-like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain.
    Moreira da Silva Santos A; Kelly JP; Dockery P; Doyle KM
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():303-309. PubMed ID: 30296469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol and aldehyde moieties of 3,4-dihydroxyphenylacetaldehyde contribute to tyrosine hydroxylase inhibition and neurotoxicity.
    Vermeer LM; Florang VR; Doorn JA
    Brain Res; 2012 Sep; 1474():100-9. PubMed ID: 22877852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
    Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS
    Brain Res; 2003 Nov; 989(2):205-13. PubMed ID: 14556942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of tyrosine hydroxylase in the loss of psychostimulant effect of amphetamine under conditions of impaired dopamine transporter activity.
    Janenaite E; Vengeliene V; Bespalov A; Behl B
    Behav Brain Res; 2017 Sep; 334():105-108. PubMed ID: 28750831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
    Klongpanichapak S; Phansuwan-Pujito P; Ebadi M; Govitrapong P
    Neurosci Lett; 2008 May; 436(3):309-13. PubMed ID: 18406059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
    Yokoyama H; Takagi S; Watanabe Y; Kato H; Araki T
    J Neural Transm (Vienna); 2008 Jun; 115(6):831-42. PubMed ID: 18235988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
    Goldstein DS
    Semin Neurol; 2020 Oct; 40(5):502-514. PubMed ID: 32906170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hippocampal excitability and impaired spatial memory function in mice lacking VGLUT2 selectively in neurons defined by tyrosine hydroxylase promoter activity.
    Nordenankar K; Smith-Anttila CJ; Schweizer N; Viereckel T; Birgner C; Mejia-Toiber J; Morales M; Leao RN; Wallén-Mackenzie Å
    Brain Struct Funct; 2015 Jul; 220(4):2171-90. PubMed ID: 24802380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Miller DB; O'Callaghan JP; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.
    Wey MC; Fernandez E; Martinez PA; Sullivan P; Goldstein DS; Strong R
    PLoS One; 2012; 7(2):e31522. PubMed ID: 22384032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.